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Periodontitis is a chronic inflammatory disease of the supporting tissues of the teeth and 1 is estimated to affect around 30% of the adult population with severe forms affecting 5-10% 2 (20). Porphyromonas gingivalis a Gram-negative, asaccharolytic anaerobe that relies on the 3 catabolism of amino acids for the production of metabolic energy is considered to be a major 4 pathogen in chronic periodontitis. P. gingivalis and other oral bacterial species exist in vivo as 5 a biofilm called subgingival plaque accreted to the surface of the tooth root. Sessile P. 6 gingivalis cells can release antigens, toxins and hydrolytic enzymes such as LPS, proteinases 7 and hemagglutinins that stimulate a host immune response. However the host response is not 8 very effective at eliminating bacteria within biofilms and a chronic inflammatory response 9 results in tissue destruction and ultimately tooth loss (13) . 10
Fumarate respiration is the most widespread type of anaerobic respiration (12). In a 11 previous comparative proteomic analysis of P. gingivalis a 2.9-and 4.0-fold reduction of two 12 components of the trimeric P. gingivalis fumarate reductase (Frd) complex (FrdA and FrdB, 13 respectively) was observed during heme-limited growth of the bacterium (6). The lower 14 abundance of the Frd complex correlated with the diminished growth (6). Smith et al (22) Concentrations (MICs) of the anthelmintics on planktonic P. gingivalis were determined in a 4 96 well plate assay with a starting inoculum of ~5.0 x 10 7 cfu per well essentially as described 5 previously (14) . Two strains of P. gingivalis were used for the planktonic growth inhibition 6 assays, ATCC 33277 a fimbriated strain that readily forms biofilms and strain W50 an 7 afimbriated strain which poorly forms biofilms. Oxantel pamoate had the most significant 8 effect of the three inhibitors on planktonic growth of P. gingivalis. The MIC of oxantel was 9 125 µM for P. gingivalis 33277 and 112 µM for P. gingivalis W50 (Table 1 ). There was a 10 significant inhibitory effect of oxantel on the growth of P. gingivalis 33277 and W50 at 11 concentrations as low as 31.25 µM. There was also a correlation of increasing oxantel 12 concentration with longer MGT at sub-minimal inhibitory concentrations (subMICs) ( Table  13 1). The planktonic MICs of oxantel for the P. gingivalis strains reported here are more than 14 six times lower than that reported for H. pylori and C. jejuni even though the cell numbers 15 used for the P. gingivalis MIC determinations were ~10 times higher than those used with H. 16 pylori (15-17). The MIC of morantel citrate for P. gingivalis was similar to that reported for 17 H. pylori whereas there was minimal P. gingivalis growth inhibition with thiabendazole, 18 possibly related to the drug's extremely low solubility (18). 19
Effects of oxantel on P. gingivalis biofilm formation. Biofilm formation over 24 h 20 in a static 96 well model was conducted essentially as described previously using crystal 21 violet to quantitate biofilm mass (3, 19) . All concentrations of oxantel tested significantly 22 reduced the biofilm biomass after 24 h and oxantel concentrations above 125 µM effectively 23 abolished biofilm formation ( Infusion broth. To determine the effect of oxantel on an established P. gingivalis biofilm, 1 6 mL of 125 or 12.5 µM oxantel pamoate dissolved in sterile water or sterile water (control) 7 was injected into each channel of the system 18 h after inoculation and incubated for 30 min. 8
The flow of medium was then resumed for another 10 min to wash off any unbound cells. 9
Confocal Laser Scanning Microscopy (CLSM) of the bacterial biofilms was carried out on a 10
Meta 510 Confocal Microscope with an inverted stage (Zeiss). BacLight stain (Molecular 11
Probes) was used to stain the biofilms in situ. The biometric parameters of the biofilm were 12 determined from five images at random positions from each of the biological replicates 13 obtained at wavelengths of 488 nm and 568 nm. All images obtained were analysed using 14 COMSTAT software (9). After 18 h of incubation in the flow cell P. gingivalis ATCC 33277 15 produced a structured biofilm that featured many microcolonies that formed 'towers' or 16 'mushrooms' that had a maximum height of ~14 µm and over 40% of the surface area of the 17 substratum was colonized by bacterial cells (Fig. 2) . A single oxantel treatment at both tested 18 concentrations caused significant reductions in both biovolume and average thickness of the 19 biofilm. Oxantel treatment affected the structure of the P. gingivalis biofilms as seen by the 20 significant increases in the surface area of the biofilm to biovolume ratio relative to the 21 control, the decrease in the size of microcolonies and the decrease in area of the surface of the 22 substratum that had attached cells at the higher oxantel concentration. (Table 2, Fig. 3) . The 23 confocal images of the biofilms showed a decrease of tower height (or maximum biofilm 24 thickness) after treatment with 12.5 µM oxantel to below 10 µm whereas 125 µM oxantel 25 on November 3, 2017 by guest http://aac.asm.org/ Downloaded from 6 treatment reduced tower height to below 6 µm which is commensurate with the changes in 1 surface area of biofilm to biovolume ratio and microcolony size (Fig. 3, Table 2 ). 2 Incorporation of a low oxantel concentration (12.5 µM) into the growth medium in the 3 flow cell also had significant effects on the formation of biofilms by P. gingivalis, decreasing 4 biovolume by 52% and average biofilm thickness by 74% (Table 3) . In a similar manner to 5 that seen with the treatment of established biofilms there was a significant increase in the 6 surface area of the biofilm to biovolume ratio ( Table 3) . Interestingly there was no significant 7 decrease in the surface area of the substratum that was colonized by bacterial cells, indicating 8 that oxantel doesn't interfere with attachment of the bacterium to the substratum. A current 9 treatment option for refractory chronic periodontitis is the systemic administration of the 10 antibiotic metronidazole. Metronidazole was also incorporated into the growth medium at a 11 concentration of 12.5 µM and this significantly reduced the biovolume and average thickness 12
of an 18 h P. gingivalis biofilm ( Table 3) . However the reductions in biovolume and average 13 thickness were significantly less than those produced by oxantel and in addition 14 metronidazole had no significant effect on the surface area of the biofilm to biovolume ratio 15 or the number of microcolonies present (Table 3) . This suggests that metronidazole only 16 affected P. gingivalis cells at the surface of the biofilm structures resulting in a reduced 17 biovolume but a structurally similar biofilm. Oxantel at the same concentration caused a 18 significantly higher reduction in biovolume and average thickness than metronidazole and 19 significantly increased the surface area of the biofilm to biovolume ratio as well as decreasing 20 the number of microcolonies. These data indicate that oxantel is more effective than 21 metronidazole in inhibiting P. gingivalis biofilms and that its mechanism of action is distinct 22 from that of metronidazole. An advantage of oxantel is its ability to selectively inhibit strictly 23 anaerobic bacterial species (pathogens) but not the commensal aerotolerant anaerobes or 24 aerobic bacteria as these species lack fumarate reductase. 25 
